CABOTEGRAVIR SODIUM

UNII:	3L12PT535M
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₉H₁₆F₂N₃O₅.Na
Preferred Substance Name:	CABOTEGRAVIR SODIUM
InChIKey:	AEZBWGMXBKPGFP-KIUAEZIZSA-M
GSRS Full Record:	3L12PT535M i

1051375-13-3
CABOTEGRAVIR SODIUM [JAN]
CABOTEGRAVIR SODIUM [ORANGE BOOK]
CABOTEGRAVIR SODIUM [USAN]
Cabotegravir Sodium
Cabotegravir sodium [MI]
Cabotegravir sodium [WHO-DD]
GSK-1265744B
GSK1265744B
OXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-2,3,5,7,11,11A-HEXAHYDRO-6-HYDROXY-3-METHYL-5,7-DIOXO-, SODIUM SALT (1:1), (3S,11AR)-
S-265744B
Sodium (3S,11aR)-8-{[(2,4-difluorophenyl)methyl]carbamoyl}-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
VOCABRIA

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CABOTEGRAVIR SODIUM

Synonyms and Mappings

Resources